Telix Pharmaceuticals reports Q1 results; reaffirms FY26 outlook.
Share this article
Earnings
Score 35
Neutral
Telix Pharmaceuticals reports Q1 results; reaffirms FY26 outlook
Apr 07, 2026 07:49 UTC
TLX
Short term
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.